Article

jdsupra.com on 2021-12-29 18:36

FDA Approves Coherus’ Adalimumab Biosimilar YUSIMRY™

Last week, Coherus BioSciences, Inc. (“Coherus”) announced that the United States Food and Drug Administration (“FDA”) approved YUSIMRY™, an ...

Denny Lanfear

Related news

FDA Approves Boehringer Ingelheim’s Adalimumab Biosimilar jdsupra.com
Ingelheim am Rhein
FDA Approves Pfizer’s Adalimumab Biosimilar ABRILADA jdsupra.com
California , United States , Switzerland
FDA Approves Second Pegfilgrastim Biosimilar, a First for Coherus jdsupra.com
California , United States , Switzerland
Sandoz Obtains FDA Approval for Adalimumab Biosimilar jdsupra.com
California , United States , Switzerland
FDA Approves 25th Biosimilar jdsupra.com
California , United States , Switzerland
Teva and Alvotech’s Adalimumab Biosimilar Receives Interchangeable Status at FDA jdsupra.com
United States , Saudi Arabia , Canada , Switzerland , United Kingdom
Celltrion Files IND with FDA for Adalimumab Biosimilar jdsupra.com
United States , South Korea
FDA Approves First Avastin Biosimilar jdsupra.com
FDA Approves Third Biosimilar Product jdsupra.com
FDA Approves First Rituximab Biosimilar jdsupra.com
California , United States , Switzerland
FDA Approves Rheumatoid Arthritis Biosimilar wsj.com
Europe , Australia , Mexico , Canada
FDA Approves First Biosimilar Drug wsj.com
Europe , China , Wall Street
FDA Approves Sandoz’s Biosimilar Pegfilgrastim jdsupra.com
California , United States , Switzerland
FDA Approves Sandoz Filgrastim Biosimilar jdsupra.com
FDA Approves Lantus® Interchangeable Biosimilar jdsupra.com
FDA Approves Pfizer’s EPO Biosimilar jdsupra.com
FDA Approves Another Interchangeable Biosimilar jdsupra.com
FDA Approves Celltrion’s Trastuzumab Biosimilar jdsupra.com
California , United States , Switzerland
FDA Approves Mylan’s Biosimilar of HUMIRA (Adalimumab)jdsupra.com
Recent Adalimumab Biosimilar Developments jdsupra.com